Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01633827 · ClinicalTrials.gov registry record · NA
Combination Therapy to Treat Sleep Apnea
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01633827 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 22 participants.
The verdict
NCT01633827, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
In Obstructive sleep apnea (OSA), the upper airway closes over and over again during sleep. This leads to disrupted sleep (waking up during the night), daytime sleepiness, and an increased risk for developing high blood pressure. Currently, the best treatment for obstructive sleep apnea is sleeping with a mask that continuously blows air into the nose (i.e. Continuous positive airway pressure \[CPAP\] treatment). While CPAP treatment stops the upper airway from closing in most people, many people have difficulty sleeping with the mask in place and therefore do not use the CPAP treatment. This research study is being conducted to learn whether using a combination of therapies (i.e. a sedative and oxygen therapy) will improve OSA severity by altering some of the traits that are responsible for the disorder.
Interventions
- DRUG Placebo pill
- OTHER Room air
- OTHER Oxygen
- DRUG Sedative
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01633827
The ClinicalTrials.gov registry entry for NCT01633827 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo pill is the first listed.
NCT01633827 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01633827 about?
NCT01633827 is a clinical study titled "Combination Therapy to Treat Sleep Apnea". In Obstructive sleep apnea (OSA), the upper airway closes over and over again during sleep. This leads to disrupted sleep (waking up during the night), daytime sleepiness, and an increased risk for developing high blood pressure. Currently, the best treatment for obstructive sleep apnea is sleeping ...
What is the current status of trial NCT01633827?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2012-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01633827?
The interventions under investigation include: Placebo pill (DRUG), Room air (OTHER), Oxygen (OTHER), Sedative (DRUG).
Who is sponsoring clinical trial NCT01633827?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.